NJ State Employees Deferred Compensation Plan’s AMAG Pharmaceuticals AMAG Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,000	Closed	-$348K	–	391
2016 Q4	$348K	Hold	10,000	–	–	0.07%	302
2016 Q3	$245K	Hold	10,000	–	–	0.05%	326
2016 Q2	$239K	Hold	10,000	–	–	0.05%	330
2016 Q1	$251K	Hold	10,000	–	–	0.05%	331
2015 Q4	$302K	Hold	10,000	–	–	0.06%	322
2015 Q3	$397K	Sell	10,000 -30,000	-75%	-$1.86M	0.09%	298
2015 Q2	$2.76M	Hold	40,000	–	–	0.54%	40
2015 Q1	$2.19M	Hold	40,000	–	–	0.42%	55
2014 Q4	$1.7M	Hold	40,000	–	–	0.33%	76
2014 Q3	$1.28M	Hold	40,000	–	–	0.26%	113
2014 Q2	$828K	Hold	40,000	–	–	0.16%	216
2014 Q1	$774K	Hold	40,000	–	–	0.16%	233
2013 Q4	$972K	Hold	40,000	–	–	0.2%	174
2013 Q3	$858K	Hold	40,000	–	–	0.19%	184
2013 Q2	$890K	Buy	+40,000	New	+$881K	0.2%	162

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's AMAG Position: Q1 2017 in Review

NJ State Employees Deferred Compensation Plan sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 10,000 shares — an estimated $348K sold.

NJ State Employees Deferred Compensation Plan first reported a position in AMAG in Q2 2013 and held it in 15 quarters. The position peaked at $2.76M in Q2 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

NJ State Employees Deferred Compensation Plan reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 10,000 AMAG Pharmaceuticals shares in Q1 2017, an estimated $348K.
NJ State Employees Deferred Compensation Plan first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 15 quarters.
NJ State Employees Deferred Compensation Plan's AMAG Pharmaceuticals position peaked at $2.76M in Q2 2015.
185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2017, filed 27 Apr 2017.